Latest Oncologists Stories
Eight abstracts will highlight enzalutamide studies in prostate and breast cancers NORTHBROOK, Ill. and SAN FRANCISCO, May 14, 2014 /PRNewswire/ -- Astellas Pharma US, Inc., a U.S.
‘Op-Ed on Cancer’ challenges traditional approach to cancer treatment, offers author’s 35-year experience as proof. Douglaston, N.Y.
Kia Michel, MD, of Comprehensive Urology in Los Angeles comments on the importance of seeking testicular cancer treatment after a 21-year-old’s life is saved thanks to social media platform
CAMBRIDGE, Mass., April 30, 2014 /PRNewswire/ -- Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company
NEW YORK, April 28, 2014 /PRNewswire/ -- Elsevier [http://www.elsevier.com ], world-leading provider of scientific, technical and medical information products and services,
BOTHELL, Wash. and VANCOUVER, British Columbia, April 28, 2014 /PRNewswire/ -- OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) today announced results from the Phase 3 SYNERGY trial.
Will oversee Virginia G.
Fort Lauderdale-based event to provide stomach cancer patients and their families unparalleled access to hear from eight world-renowned experts in the field of stomach cancer FT.
Third Phase 3 Trial of Custirsen to Receive FDA Fast Track Designation BOTHELL, Wash.
Fox Family Cancer Research Funding Trust Is Contributing to Support Team SAN DIEGO, April 7, 2014 /PRNewswire-USNewswire/ -- Stand
- An armed gangster.